The DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
Open accessAbstract
The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant infections. A previous guidance document focused on infections caused by extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Here, guidance is provided for treating AmpC β-lactamase–producing Enterobacterales (AmpC-E), carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia infections. A panel of 6 infectious diseases specialists with expertise in managing antimicrobial-resistant infections formulated questions about the treatment of AmpC-E, CRAB, and S. maltophilia infections. Answers are presented as suggested approaches and corresponding rationales. In contrast to guidance in the previous document, published data on the optimal treatment of AmpC-E, CRAB, and S. maltophilia infections are limited. As such, guidance in this document is provided as “suggested approaches” based on clinical experience, expert opinion, and a review of the available literature. Because of differences in the epidemiology of resistance and availability of specific anti-infectives internationally, this document focuses on the treatment of infections in the United States. Preferred and alternative treatment suggestions are provided, assuming the causative organism has been identified and antibiotic susceptibility results are known. Approaches to empiric treatment, duration of therapy, and other management considerations are also discussed briefly. Suggestions apply for both adult and pediatric populations. The field of antimicrobial resistance is highly dynamic. Consultation with an infectious diseases specialist is recommended for the treatment of antimicrobial-resistant infections. This document is current as of 17 September 2021 and will be updated annually. The most current version of this document, including date of publication, is available at www.idsociety.org/practice-guideline/amr-guidance-2.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–318 of 318
Tato, M., García-Castillo, M., Bofarull, A. M., & Cantón, R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.004 · Cited by 63
Pfaller, M. A., Huband, M. D., Shortridge, D., & Flamm, R. K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02488-19 · Cited by 63
Fung-Tomc, J. C., Gradelski, E., Huczko, E., Dougherty, T. J., KESSLER, R. E., & BONNER, D. P. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1289 · Cited by 62
Cai, B., Tillotson, G., Benjumea, D., Callahan, P. M., & ECHOLS, R. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa141 · Cited by 62
Bernabeu‐Wittel, M., Pichardo, C., García-Curiel, A., Pachón-Ibáñez, M. E., Ibáñez-Martínez, J., Me, J.-M., & Pachón, J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01095.x · Cited by 60
Beganovic, M., Daffinee, K. E., Luther, M. K., & LaPlante, K. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01680-20 · Cited by 60
Kuo, S., Lee, Y.-T., Yang, S.-P., Chen, C.-P., Chen, T.-L., Hsieh, S.-L., Siu, L.-K. K., & Fung, C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03682.x · Cited by 58
Niu, T., Luo, Q., Li, Y., Zhou, Y., Yu, W., & Xiao, Y. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0502-x · Cited by 58
Flamm, R. K., Shortridge, D., Castanheira, M., Sader, H. S., & Pfaller, M. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01154-19 · Cited by 58
Assimakopoulos, S. F., Karamouzos, V., Lefkaditi, A., Sklavou, C., Kolonitsiou, F., Christofidou, M., Fligou, F., Gogos, C. A., & Marangos, M. N. (2019) · PubMed · Cited by 58
Pogue, J. M., Neelakanta, A., Mynatt, R. P., Sharma, S., Lephart, P., & Kaye, K. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu594 · Cited by 57
Barnaud, G., Benzerara, Y., Gravisse, J., Raskine, L., Pors, M.-J. S.-L., Labia, R., & Arlet, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1040-1042.2004 · Cited by 57
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients
Rolston, K. V. I., Gerges, B., Shelburne, S. A., Aitken, S. L., RAAD, I. I., & Prince, R. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01955-19 · Cited by 57
Self-citationO’Donnell, J. N., Putra, V., & Lodise, T. P. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2607 · Cited by 57
Inhaled colistin as monotherapy for multidrug-resistant gram (−) nosocomial pneumonia: A case series
Falagas, M. E., Siempos, I. Ι., Rafailidis, P. I., Korbila, I. P., Ioannidou, E., & Michalopoulos, A. S. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.018 · Cited by 56
Lin, C.-C., Liu, T.-C., Kuo, C.-F., Liu, C.-P., & Lee, C.-M. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60050-3 · Cited by 56
Amat, T., Gutiérrez-Pizarraya, A., Machuca, I., Gracia-Ahufinger, I., Pérez‐Nadales, E., Torre‐Giménez, Á., Garnacho‐Montero, J., Cisneros, J. M., & Torre‐Cisneros, J. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.09.016 · Cited by 56
García‐León, G., Puig, C. R. D. A., de la Fuente, C. G., Martínez-Martínez, L., Martínez, J. L., & Sánchez, M. B. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.01.007 · Cited by 55
Towfigh, S., Pasternak, J., Poirier, A., Leister, H., & Babinchak, T. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03122.x · Cited by 55
Ku, N. S., Lee, S.-H., Lim, Y. S., Choi, H., Ahn, J. Y., Jeong, S. J., Shin, S. J., Choi, J. Y., Choi, Y. H., Yeom, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53714-0 · Cited by 55
Biagi, M. J., Lamm, D., Meyer, K., Vialichka, A., Jurkovic, M., Patel, S., Mendes, R. E., Bulman, Z. P., & Wenzler, E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-20 · Cited by 55
Tselepis, L., Langley, G. W., Aboklaish, A. F., Widlake, E., Jackson, D. E., Walsh, T. R., Schofield, C. J., Brem, J., & Tyrrell, J. M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105925 · Cited by 54
Tada, K., Kurosawa, S., Hiramoto, N., Okinaka, K., Ueno, N., Asakura, Y., Kim, S.-W., Yamashita, T., Mori, S.-I., Heike, Y., et al. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.87 · Cited by 53
Chen, Z., & Shi, X. (2018) · Medicine · doi:10.1097/md.0000000000012467 · Cited by 53
Nys, C., Cherabuddi, K., Venugopalan, V., & Klinker, K. P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00788-19 · Cited by 53
Gordon, N. C., & Wareham, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp476 · Cited by 52
Shah, M. D., Coe, K. E., Boghdadly, Z. E., Wardlow, L. C., Dela‐Pena, J., Stevenson, K., & Reed, E. E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz116 · Cited by 51
Sulbactam: a beta-lactamase inhibitor.
Noguchi, J. K., & Gill, M. A. (1988) · PubMed · Cited by 50
Lodise, T. P., Wart, S. V., Sund, Z. M., Bressler, A. M., Khan, A., Makley, A. T., Hamad, Y., Salata, R. A., Silveira, F. P., Sims, M. D., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01809-20 · Cited by 50
Crandon, J. L., Kim, A., & Nicolau, D. P. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp301 · Cited by 49
Ba, B. B., Feghali, H., Arpin, C., Saux, M., & Quentin, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.946-953.2004 · Cited by 49
Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica
Seoane, A., Francia, M. V., & Lobo, J. M. G. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.1049 · Cited by 49
Kim, S., Cha, M. K., Kang, C., Ko, J., Huh, K., Cho, S. Y., Chung, D. R., & Peck, K. R. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3425-1 · Cited by 49
Elliott, Z. S., Barry, K. E., Cox, H. L., Stoesser, N. E., Carroll, J., Vegesana, K. B., Kotay, S. M., Sheppard, A. E., Wailan, A. M., Crook, D. W., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00634-19 · Cited by 49
Self-citationGolden, A., Adam, H. J., Baxter, M. R., Walkty, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., & Zhanel, G. G. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115012 · Cited by 49
Penicillin-binding proteins and induction of AmpC beta-lactamase
Sanders, C. C., Bradford, P. A., Ehrhardt, A. F., Bush, K., Young, K. D., Henderson, T. A., & Sanders, W. E. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2013 · Cited by 47
Sader, H. S., Duncan, L. R., Arends, S. J. R., Carvalhaes, C. G., & Castanheira, M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01433-20 · Cited by 47
Enhancing Resistance to Cephalosporins in Class C β-Lactamases: Impact of Gly214Glu in CMY-2
Endimiani, A., Doi, Y., Bethel, C. R., Taracila, M. A., Adams‐Haduch, J. M., O’Keefe, A., Hujer, A. M., Paterson, D. L., Skalweit, M. J., Page, M. G. P., et al. (2009) · Biochemistry · doi:10.1021/bi9015549 · Cited by 46
Self-citationŞimşek, F., Gedık, H., Yıldırmak, T., İris, N., Türkmen, A., Ersoy, A., Ersöz, M., & Gücüyener, A. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.103767 · Cited by 46
Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia
Song, W., Moland, E. S., Hanson, N. D., Lewis, J. S., Jorgensen, J. H., & Thomson, K. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4891-4894.2005 · Cited by 46
Yang, Y., Lee, Y., Tseng, K.-C., Huang, W., Chuang, M.-F., Kuo, S., Lauderdale, T.-L. Y., & Chen, T.-L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02994-15 · Cited by 46
Jang, J. Y., Kwon, H. Y., Choi, E. H., Lee, W., Shim, H., & Bae, K. S. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.04.004 · Cited by 46
Tan, S. H., Ng, T. M., Chew, K. L., Yong, J., Wu, J. E., Yap, M. Y., Heng, S. T., Ng, W. H. W., Shilin, W., Cheok, S. J. H., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.105860 · Cited by 46
Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections
Tekce, Y. T., Erbay, A., Çabadak, H., & Şen, S. (2012) · Journal of Chemotherapy · doi:10.1179/1120009x12z.00000000022 · Cited by 44
Lim, S.-K., Lee, S., Choi, S., Choi, J., Kim, S., Jeong, J., Choi, S., Woo, J. H., & Kim, Y. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.3.325 · Cited by 44
Araoka, H., Fujii, T., Izutsu, K., Kimura, M., Nishida, A., Ishiwata, K., Nakano, N., Tsuji, M., Yamamoto, H., Asano‐Mori, Y., et al. (2012) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00710.x · Cited by 44
Khan, A., Arias, C. A., Abbott, A., Bard, J. D., Bhatti, M. M., & Humphries, R. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00654-21 · Cited by 44
Pseudomonas aeruginosa Susceptible Only to Colistin in Intensive Care Unit Patients
Mastoraki, A. T., Douka, E., Kriaras, I., Stravopodis, G., Manoli, H., & Geroulanos, S. (2008) · Surgical Infections · doi:10.1089/sur.2007.004 · Cited by 43
Bonfiglio, G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.115 · Cited by 43
Antibacterial in vitro activity of fourth generation cephalosporins.
Hancock, R. E. W., & Bellido, F. (1996) · PubMed · Cited by 43
Kim, Y. K., Lee, J. H., Lee, H.-K., Chung, B. C., Yu, S. J., Lee, H., Park, J. H., Kim, S., Kim, H.-K., Kiem, S., et al. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.02.61 · Cited by 42
Trebosc, V., Schellhorn, B., Schill, J., Lucchini, V., Bühler, J., Bourotte, M., Butcher, J. J., Gitzinger, M., Lociuro, S., Kemmer, C., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa370 · Cited by 42
Ye, J.-J., Lin, H.-S., Kuo, A.-J., Leu, H., Chiang, P.-C., Huang, C., & Lee, M. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.08.001 · Cited by 41
Mohammadi, M., Khayat, H., Sayehmiri, K., Soroush, S., Sayehmiri, F., Delfani, S., Bogdanović, L., & Taherikalani, M. (2017) · The Open Microbiology Journal · doi:10.2174/1874285801711010063 · Cited by 41
Hamdi, A., Fida, M., Saleh, O. A., & Beam, E. N. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa008 · Cited by 41
Rapid Emergence of Resistance to Cefepime During Treatment
Limaye, A. P., Gautom, R., Black, D. J., & Fritsche, T. R. (1997) · Clinical Infectious Diseases · doi:10.1086/516917 · Cited by 40
Pournaras, S., Koumaki, V., Gennimata, V., Kouskouni, E. E., & Tsakris, A. (2015) · Advances in experimental medicine and biology · doi:10.1007/5584_2015_5001 · Cited by 40
Yu, V. L., Felegie, T. P., Vee, R. B., Pasculle, A. W., & Taylor, F. H. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/142.4.602 · Cited by 39
Hernández‐Torres, A., García‐Vázquez, E., Gómez, J., Canteras, M., Ruiz, J., & Yagüe, G. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.06.024 · Cited by 38
Chaubey, V. P., Pitout, J. D. D., Dalton, B., Gregson, D. B., Ross, T., & Laupland, K. B. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0647-4 · Cited by 38
Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam
Jaruratanasirikul, S., Wongpoowarak, W., Aeinlang, N., & Jullangkoon, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-13 · Cited by 38
Kang, C.-H., Tsai, C., Wu, T.-H., Wu, H.-Y., Chung, M., Chen, C., Huang, Y., Liu, S., Liao, D., Niu, C.-K., et al. (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22750 · Cited by 38
Qvist, N., Warren, B., Leister-Tebbe, H. K., Zito, E. T., Pedersen, R. D., McGovern, P. C., & Babinchak, T. (2012) · Surgical Infections · doi:10.1089/sur.2011.048 · Cited by 38
Chen, I. H., Kidd, J. M., Abdelraouf, K., & Nicolau, D. P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01558-19 · Cited by 38
Lin, Q., Zou, H., Chen, X., Wu, M., Ma, D., Yu, H., Niu, S., & Huang, S. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02108-2 · Cited by 38
Montaña, S., Vilacoba, E., Traglia, G. M., Almuzara, M. N., Pennini, M., Fernández, A., Sucari, A., Centrón, D., & Ramirez, M. S. (2015) · Current Microbiology · doi:10.1007/s00284-015-0829-3 · Cited by 37
Wei, C., Ni, W., Cai, X., & Cui, J. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1064542 · Cited by 37
Abdul‐Mutakabbir, J. C., Yim, J., Nguyen, L., Maassen, P. T., Stamper, K. C., Shiekh, Z., Kebriaei, R., Shields, R. K., Castanheira, M., Kaye, K. S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10070880 · Cited by 37
Girlich, D., Naas, T., Bellais, S., Poirel, L., Karim, A., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3220-3223.2000 · Cited by 36
Kwon, S. H., Ahn, H. L., Han, O. Y., & La, H. O. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00109 · Cited by 36
Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-SusceptibleAcinetobacter baumannii
Choi, H. K., Kim, Y. K., Kim, H. Y., & Uh, Y. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.1.118 · Cited by 36
Joly‐Guillou, M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.827 · Cited by 36
Martínez-Servat, S., Yero, D., Huedo, P., Marquez, R., Molina, G., Daura, X., & Gibert, I. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02871 · Cited by 35
Hsieh, T.-C., Chen, F.-L., Ou, T.-Y., Jean, S., & Lee, W. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.08.009 · Cited by 34
Flamm, R. K., Castanheira, M., Streit, J. M., & Jones, R. N. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.03.019 · Cited by 34
Araoka, H., Baba, M., Okada, C., Abe, M., Kimura, M., & Yoneyama, A. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.02.020 · Cited by 34
Cowart, M. C., & Ferguson, C. L. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000857 · Cited by 34
Cheng, J., Yan, J., Reyna, Z., Slarve, M. J., Lu, P., Spellberg, B. J., & Luna, B. M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02204-20 · Cited by 34
Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit
Ganapathy, H., Pal, S. K., Teare, L., & Dziewulski, P. G. (2009) · Burns · doi:10.1016/j.burns.2009.07.010 · Cited by 32
Cefiderocol: the Trojan horse has arrived but will Troy fall?
Heil, E. L., & Tamma, P. D. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30828-8 · Cited by 32
Self-citationPenetration of Minocycline Hydrochloride into Lung Tissue and Sputum
Watanabe, A., Watanabe, A., Anzai, Y., Anzai, Y., Niitsuma, K., Niitsuma, K., Saito, M., Saito, M., Yanase, K., Yanase, K., et al. (2000) · Chemotherapy · doi:10.1159/000048494 · Cited by 31
Wu, C.-J., Lu, H.-F., Lin, Y.-T., Zhang, M.-S., Li, L.-H., & Yang, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00822 · Cited by 30
Underwood, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh235 · Cited by 29
Distressing Side-Effects of Minocycline Hydrochloride
Fanning, W. L. (1976) · Archives of Internal Medicine · doi:10.1001/archinte.1976.03630070009005 · Cited by 29
Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections
Wenzler, E., Goff, D. A., Humphries, R. M., & Goldstein, E. J. C. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0149-y · Cited by 29
Khan, A., Pettaway, C. H., Bard, J. D., Arias, C. A., Bhatti, M. M., & Humphries, R. M. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02631-20 · Cited by 29
Fatal Acinetobacter baumannii Infection with Discordant Carbapenem Susceptibility
Lesho, E. P., Wortmann, G. W., Moran, K., & Craft, D. W. (2005) · Clinical Infectious Diseases · doi:10.1086/432623 · Cited by 28
Cheng, M. P., Lee, R. S., Cheng, A. P., l’Étoile-Morel, S. D., Demir, K. K., Yansouni, C. P., Harris, P. N. A., McDonald, E. G., & Lee, T. C. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz248 · Cited by 27
Carbapenem Susceptibility Discords among Acinetobacter Isolates
Jones, R., Sader, H. S., Fritsche, T. R., & Rhomberg, P. R. (2005) · Clinical Infectious Diseases · doi:10.1086/498754 · Cited by 26
Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections
Jacobson, S., Noa, L. J., Wallace, M. R., & Bowman, M. C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw327 · Cited by 25
Phillips, M. C., Wald‐Dickler, N., Loomis, K. J., Luna, B. M., & Spellberg, B. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa460 · Cited by 25
Karaba, S. M., Goodman, K. E., Amoah, J., Cosgrove, S. E., & Tamma, P. D. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00793-21 · Cited by 25
Self-citationWang, C.-C., Chao, T.-Y., Chen, Y., Fang, W., Kao, H., Chen, H., Tsai, Y.-C., Shen, L.-S., Li, C.-L., Chang, H., et al. (2014) · Biomedical Journal · doi:10.4103/2319-4170.132879 · Cited by 24
Taşbakan, M. S., Pullukçu, H., Sipahf, O., Taşbakan, M., Aydemir, Ş., & Bacakoğlu, F. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.6.345 · Cited by 24
Fox, M. T., Melia, M. T., Same, R. G., Conley, A. T., & Tamma, P. D. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.01.025 · Cited by 24
Self-citationRobin, F., Auzou, M., Bonnet, R., Lebreuilly, R., Isnard, C., Cattoir, V., & Guérin, F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00675-18 · Cited by 24
Biagi, M. J., Butler, D. A., Tan, X., Qasmieh, S., & Wenzler, E. (2019) · Antibiotics · doi:10.3390/antibiotics8010027 · Cited by 24
In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017–2018
Dong, D., Zheng, Y., Chen, Q., Guo, Y. P., Yang, Y., Wu, S., Zhu, D., Deng, D., Bradford, P. A., Reinhart, H. H., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03877-w · Cited by 24
Characterization of Indole-Positive Proteus mirabilis
Matsen, J. M., Blazevic, D. J., Ryan, J. A., & Ewing, W. H. (1972) · Applied Microbiology · doi:10.1128/am.23.3.592-594.1972 · Cited by 22
Stewart, A. G., Harris, P. N. A., Chatfield, M. D., Littleford, R. C., & Paterson, D. L. (2021) · Trials · doi:10.1186/s13063-021-05206-8 · Cited by 22
Giamarellos‐Bourboulis, E. J., Karnesis, L., Galani, I., & Giamarellou, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3997-3999.2002 · Cited by 21
In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii
Noel, A., Attwood, M., Bowker, K. E., & MacGowan, A. P. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa508 · Cited by 21
The Role of Aerolized Colistin in the Treatment of Hospital-Acquired Pneumonia
Ekren, P. K., Töreyin, Z. N., Sayıner, A., & Bacakoğlu, F. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001539 · Cited by 19
Derrick, C., Bookstaver, P. B., Lu, K., Bland, C. M., King, S. T., Stover, K. R., Rumley, K. F., MacVane, S. H., Swindler, J., Kincaid, S. E., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9050254 · Cited by 19
Jean, S., Hsieh, T.-C., Lee, W., Hsueh, P., Hsu, C.-W., & Lam, C. (2018) · Medicine · doi:10.1097/md.0000000000012278 · Cited by 18
Negri, M.-C., & Baquero, F. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00721.x · Cited by 18
Al‐Dorzi, H. M., Asiri, A., Shimemri, A., Tamim, H., Johani, S. M. A., Dabbagh, T., & Arabi, Y. M. (2015) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.164302 · Cited by 17
Esterly, J. S., Qi, C., Malczynski, M., & Scheetz, M. H. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.4.354 · Cited by 17
Baek, J. H., Kim, C. O., Jeong, S. J., Ku, N. S., Han, S. H., Choi, J. Y., Yong, D., Song, Y. G., Lee, K., & Kim, J. M. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.4.987 · Cited by 17
Lee, Y., Wang, Y.-C., Kuo, S., Chen, C.-T., Liu, C.-P., Liu, Y.-M., Chen, T.-L., & Yang, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00931-17 · Cited by 17
Diarra, A., Pascal, L. B., Carpentier, B., Baclet, N., Cabaret, P., Georgel, A., Dubreuil, L. J., & Weyrich, P. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2021.01.014 · Cited by 17
Sears, C. L., File, T. M., Alexander, B. D., McQuillen, D. P., MacIntyre, A. T., Allen, U., Colasanti, J. A., Siddiqui, J., Reveles, K. R., Busky, C., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1040 · Cited by 16
Klimkaitė, L., Armalytė, J., Skerniškytė, J., & Sužiedėlienė, E. (2020) · Toxins · doi:10.3390/toxins12100635 · Cited by 15
Liu, C., Wang, X., Chen, Y., Hao, H., Li, X., Liang, J., Duan, R., Li, C., Zhang, J., Shao, S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01282 · Cited by 13
Eliopoulos, G. M. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.supplement_a.37 · Cited by 12
Widmer, A. F., Kern, W. V., Roth, J. A., Dettenkofer, M., Götting, T., Bertz, H., & Theilacker, C. (2019) · Infection · doi:10.1007/s15010-019-01327-0 · Cited by 11
Imoto, W., Kaneko, Y., Yamada, K., Kuwabara, G., Yamairi, K., Shibata, W., Oshima, K., Niki, M., Nakaie, K., Watanabe, T., et al. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.10.024 · Cited by 11
Talan, D. A., Stamm, W. E., Hooton, T. M., Moran, G. J., Burke, T., Iravani, A., Reuning-Scherer, J., & Church, D. A. (2000) · JAMA · doi:10.1001/jama.283.12.1583
Cited by
A novel antibiotic class targeting the lipopolysaccharide transporter
Zampaloni, C., Mattei, P., Bleicher, K., Winther, L., Thäte, C., Bucher, C., Adam, J.-M., Alanine, A., Amrein, K. E., Baidin, V., et al. (2024) · Nature · doi:10.1038/s41586-023-06873-0 · Cited by 308
Treatment of Acinetobacter baumannii severe infections
Reina, R., León-Moya, C., & Garnacho-Montero, J. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.08.007 · Cited by 22
Metadata
- Authors
- Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-12-05
- Volume
- 74
- Issue
- 12
- Pages
- 2089-2114
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4200036649
- Cited by
- 519
- References
- 318
- FWCI
- 25.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.